|
1
|
Hou J, Liu Z and Gu F: Epidemiology and
prevention of hepatitis B virus infection. Int J Med Sci. 2:502005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vettori S, Gay S and Distler O: Role of
MicroRNAs in Fibrosis. Open Rheumatol J. 6:130–139. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ura S, Honda M, Yamashita T, Ueda T,
Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K and Kaneko
S: Differential microRNA expression between hepatitis B and
hepatitis C leading disease progression to hepatocellular
carcinoma. Hepatology. 49:1098–1112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang XW, Heegaard NH and Orum H: MicroRNAs
in liver disease. Gastroenterology. 142:1431–1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chinese Society of Hepatology, Chinese
Medical Association; Chinese Society of Infectious Diseases,
Chinese Medical Association: The guidelines of prevention and
treatment for chronic hepatitis B. Chin J Hepatol. 13:881–891.
2005.In Chinese.
|
|
7
|
Scheuer PJ: The nomenclature of chronic
hepatitis: Time for a change. J Hepatol. 22:112–114. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Audic S and Claverie JM: The significance
of digital gene expression profiles. Genome Res. 7:986–995.
1997.PubMed/NCBI
|
|
9
|
Mar JC, Kimura Y, Schroder K, Irvine KM,
Hayashizaki Y, Suzuki H, Hume D and Quackenbush J: Data-driven
normalization strategies for high-throughput quantitative RT-PCR.
BMC Bioinformatics. 10:1102009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park JH, Yoon J, Lee KY and Park B:
Effects of geniposide on hepatocytes undergoing
epithelial-mesenchymal transition in hepatic fibrosis by targeting
TGFβ/Smad and ERK-MAPK signaling pathways. Biochimie. 113:26–34.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu W, Huang H, Li K and Qin C:
Danshensu-mediated protective effect against hepatic fibrosis
induced by carbon tetrachloride in rats. Pathol Biol (Paris).
62:348–353. 2014. View Article : Google Scholar
|
|
12
|
Nakamura I, Zakharia K, Banini BA, Mikhail
DS, Kim TH, Yang JD, Moser CD, Shaleh HM, Thornburgh SR, Walters I
and Roberts LR: Brivanib attenuates hepatic fibrosis in vivo and
stellate cell activation in vitro by inhibition of FGF, VEGF and
PDGF signaling. PLoS One. 9:e922732014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Li X, Xu W, Wang S, Hu Z, Zhang Q,
Deng X, Wang J, Zhang J and Guo C: Antifibrotic effects of luteolin
on hepatic stellate cells and liver fibrosis by targeting
AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways. Liver Int.
35:1222–1233. 2015. View Article : Google Scholar
|
|
14
|
Zhou K and Lu LG: Assessment of fibrosis
in chronic liver diseases. J Dig Dis. 10:7–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Forns X, Ampurdanès S, Llovet JM, Aponte
J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM and
Rodés J: Identification of chronic hepatitis C patients without
hepatic fibrosis by a simple predictive model. Hepatology.
36:986–992. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Imbert-Bismut F, Ratziu V, Pieroni L,
Charlotte F, Benhamou Y and Poynard T; MULTIVIRC Group: Biochemical
markers of liver fibrosis in patients with hepatitis C virus
infection: A prospective study. Lancet. 357:1069–1075. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Y, Wang F, Huang Q, Cao Y, Zhao Y and
Yang C: MicroRNAs contribute to hepatocellular carcinoma. Mini Rev
Med Chem. 15:459–466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park K and Kim KB: miRTar Hunter: A
prediction system for identifying human microRNA target sites. Mol
Cells. 35:195–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim T and Reitmair A: Non-Coding RNAs:
Functional aspects and diagnostic utility in oncology. Int J Mol
Sci. 14:4934–4968. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: a fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar
|
|
25
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y,
Guo H, Fei M and Sun S: Plasma microRNA-122 as a biomarker for
viral-, alcohol- and chemical-related hepatic diseases. Clin Chem.
56:1830–1838. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu J, Wu C, Che X, Wang L, Yu D, Zhang T,
Huang L, Li H, Tan W, Wang C, et al: Circulating MicroRNAs, miR-21,
miR-122 and miR-223, in patients with hepatocellular carcinoma or
chronic hepatitis. Mol Carcinog. 50:136–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choo KB, Soon YL, Nguyen PN, Hiew MS and
Huang CJ: MicroRNA-5p and -3p co-expression and cross-targeting in
colon cancer cells. J Biomed Sci. 21:952014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shiu TY, Huang SM, Shih YL, Chu HC, Chang
WK and Hsieh TY: Hepatitis C virus core protein down-regulates
p21Waf1/Cip1 and inhibits curcumin-induced apoptosis through
microRNA-345 targeting in human hepatoma cells. PloS One.
8:e610892013. View Article : Google Scholar :
|
|
30
|
Li G, Qiu Y, Su Z, Ren S, Liu C, Tian Y
and Liu Y: Genome-wide analyses of radioresistance-associated miRNA
expression profile in nasopharyngeal carcinoma using next
generation deep sequencing. PLoS One. 8:e844862013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Long C, Jiang L, Wei F, Ma C, Zhou H, Yang
S, Liu X and Liu Z: Integrated miRNA-mRNA analysis revealing the
potential roles of miRNAs in chordomas. PLoS One. 8:e666762013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sand M, Skrygan M, Sand D, Georgas D, Hahn
SA, Gambichler T, Altmeyer P and Bechara FG: Expression of
microRNAs in basal cell carcinoma. Brit J Dermatol. 167:847–855.
2012. View Article : Google Scholar
|
|
33
|
Kanda T, Ishibashi O, Kawahigashi Y,
Mishima T, Kosuge T, Mizuguchi Y, Shimizu T, Arima Y, Yokomuro S,
Yoshida H, et al: Identification of obstructive jaundice-related
microRNAs in mouse liver. Hepatogastroenterology. 57:1013–1023.
2010.
|
|
34
|
Navon R, Wang H, Steinfeld I, Tsalenko A,
Ben-Dor A and Yakhini Z: Novel rank-based statistical methods
reveal microRNAs with differential expression in multiple cancer
types. PLoS One. 4:e80032009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song L, Lin C, Gong H, Wang C, Liu L, Wu
J, Tao S, Hu B, Cheng SY, Li M, et al: miR-486 sustains NF-kappaB
activity by disrupting multiple NF-kappaB-negative feedback loops.
Cell Res. 23:274–289. 2013. View Article : Google Scholar :
|
|
36
|
Furuta M, Kozaki K, Tanimoto K, Tanaka S,
Arii S, Shimamura T, Niida A, Miyano S and Inazawa J: The
tumor-suppressive miR-497-195 cluster targets multiple cell-cycle
regulators in hepatocellular carcinoma. PLoS One. 8:e601552013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo ST, Jiang CC, Wang GP, Li YP, Wang CY,
Guo XY, Yang RH, Feng Y, Wang FH, Tseng HY, et al: MicroRNA-497
targets insulin-like growth factor 1 receptor and has a tumour
suppressive role in human colorectal cancer. Oncogene.
32:1910–1920. 2013. View Article : Google Scholar :
|
|
38
|
Yadav S, Pandey A, Shukla A, Talwelkar SS,
Kumar A, Pant AB and Parmar D: miR-497 and miR-302b regulate
ethanol-induced neuronal cell death through BCL2 protein and cyclin
D2. J Biol Chem. 286:37347–37357. 2011. View Article : Google Scholar : PubMed/NCBI
|
